The American Journal of Medicine
Volume 122, Issue 9 , Pages 875-878, September 2009

Low Rates of Reporting Commercial Bias by Physicians Following Online Continuing Medical Education Activities

  • Julie A. Ellison, PhD

      Affiliations

    • Medscape LLC, New York, NY
    • Corresponding Author InformationRequests for reprints should be addressed to Julie Ellison, PhD, Medscape, LLC, 370 Seventh Avenue, Suite 1101, New York, NY 10001
    • ,
  • Charles H. Hennekens, MD

      Affiliations

    • Florida Atlantic University, Boca Raton
    • ,
  • Jing Wang, MS

      Affiliations

    • Medscape LLC, New York, NY
    • ,
  • George D. Lundberg, MD

      Affiliations

    • Medscape LLC, New York, NY
    • ,
  • Destry Sulkes, MD

      Affiliations

    • Medscape LLC, New York, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: The study was funded by Medscape, LLC.

 Conflict of Interest: Julie Ellison and Jing Wang disclose that they are employed by Medscape, LLC. George Lundberg and Destry Sulkes disclose they were employed by Medscape, LLC at the time of the preparation of the manuscript. George Lundberg is currently a Consulting Professor, Stanford University, and Distinguished Consultant, Physicians Advocates, Berkeley, Calif. Charles H. Hennekens discloses that he receives investigator initiated research grant support from Bayer to Florida Atlantic University; serves as an independent scientist either as Chair or member of the Data and Safety Monitoring Boards or as an advisor to: Actelion, Amgen, Bayer, Bristol-Myers Squibb, Canadian Institutes of Health Research, Dainippon Sumitomo, Food and Drug Administration, General Electric, GlaxoSmithKline, National Institutes of Health, Sanofi-Aventis and UpToDate; and serves as a speaker for National Association for Continuing Education, PriMed, International Atherosclerosis Society, AstraZeneca, and Pfizer.

 Authorship: The work is original and the authors meet the criteria for authorship, including acceptance of responsibility for the scientific content and writing of the article.

PII: S0002-9343(09)00413-6

doi:10.1016/j.amjmed.2009.02.026

The American Journal of Medicine
Volume 122, Issue 9 , Pages 875-878, September 2009

Article Tools